Your session is about to expire
← Back to Search
Other
oZTEo MRI pulse sequence for Rheumatoid Arthritis
N/A
Waitlist Available
Led By Naveen Murthy, MD
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Hand radiographs confirm the presence of bony erosions
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 day
Awards & highlights
Study Summary
This trial aims to study a new MRI technique called 3D DL oZTEo to detect bone erosion in the hands of patients with inflammatory arthritis. Detecting bone changes is important in diseases like
Who is the study for?
This trial is for patients with inflammatory arthritis, such as rheumatoid arthritis, who need their hand bones checked for damage. The study will use a new MRI technique to spot bone erosion.Check my eligibility
What is being tested?
The trial is testing a new MRI pulse sequence called 3D DL oZTEo. It's designed to better detect bone erosions in the hands of patients with inflammatory arthritis compared to current methods.See study design
What are the potential side effects?
Since this trial involves an imaging technique rather than a drug or invasive procedure, there are no direct side effects expected from the intervention itself.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
My X-rays show bone damage in my hands.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1 day
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 day
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
The binary (yes/no) presence of bony erosions as detected by hand MRI with and without the addition of the 3D DL oZTEo sequence.
Secondary outcome measures
The number of erosions (continuous) as detected by hand MRI with and without the addition of the 3D DL oZTEo sequence.
Trial Design
1Treatment groups
Experimental Treatment
Group I: oZTEo MRI pulse sequenceExperimental Treatment1 Intervention
All patients will have the FDA approved MRI pulse sequence, oZTEo, added to their already ordered standard of care MRI examination.
Find a Location
Who is running the clinical trial?
Mayo ClinicLead Sponsor
3,227 Previous Clinical Trials
3,771,643 Total Patients Enrolled
6 Trials studying Rheumatoid Arthritis
571 Patients Enrolled for Rheumatoid Arthritis
GE HealthcareIndustry Sponsor
292 Previous Clinical Trials
631,095 Total Patients Enrolled
Naveen Murthy, MDPrincipal InvestigatorMayo Clinic
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is the enrollment for this investigation currently open?
"Per information from clinicaltrials.gov, this specific trial is presently not seeking new participants. Despite being first listed on 6/1/2024 and last updated on 4/24/2024, it is important to note that there are a total of 369 ongoing trials actively looking for eligible candidates at this moment."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger